MURACA, IACOPO
MURACA, IACOPO
Medicina Sperimentale e Clinica
"Tailored" antiplatelet bridging therapy with cangrelor: moving toward personalized medicine.
2021 Valenti R, Muraca I, Marcucci R, Ciatti F, Berteotti M, Gori AM, Carrabba N, Migliorini A, Marchionni N, Valgimigli M
Adenosine in Interventional Cardiology: Physiopathologic and Pharmacologic Effects in Coronary Artery Disease
2024 Marchi, Enrico; Muraca, Iacopo; Berteotti, Martina; Gori, Anna Maria; Valenti, Renato; Marcucci, Rossella
P2697Percutaneous coronary intervention with 2nd generation drug eluting stent versus coronary artery bypass grafting in patients with unprotected left main disease: clinical outcome from a referral center
2019 Scudiero, F; Migliorini, A; Stefano, P L; Marcucci, R; Pennesi, M; Carrabba, N; Muraca, I; Vitale, R; Marchionni, N; Valenti, R
Pathophysiological and Molecular Basis of the Side Effects of Ticagrelor: Lessons from a Case Report
2023 Cesarini, Daniel; Muraca, Iacopo; Berteotti, Martina; Gori, Anna Maria; Sorrentino, Andrea; Bertelli, Alessia; Marcucci, Rossella; Valenti, Renato
Percutaneous coronary intervention with 2nd generation drug eluting stent versus coronary artery bypass grafting in patients with unprotected left main disease: clinical outcome from a referral center
2019 Scudiero, F; Migliorini, A; Stefano, PL; Marcucci, R; Pennesi, M; Carrabba, N; Muraca, I; Vitale, R; Marchionni, N; Valenti, R
Percutaneous left ventricular advanced support for ‘protected’ complex high-risk transcatheter mitral valve repair: a case series
2020 Iacopo Muraca, Matteo Pennesi, Nazario Carrabba, Fernando Scudiero, Angela Migliorini, Niccolò Marchionni, Pierluigi Stefàno, Renato Valenti
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| "Tailored" antiplatelet bridging therapy with cangrelor: moving toward personalized medicine. | 2021 | Valenti R, Muraca I, Marcucci R, Ciatti F, Berteotti M, Gori AM, Carrabba N, Migliorini A, Marchionni N, Valgimigli M | |
| Adenosine in Interventional Cardiology: Physiopathologic and Pharmacologic Effects in Coronary Artery Disease | 2024 | Marchi, Enrico; Muraca, Iacopo; Berteotti, Martina; Gori, Anna Maria; Valenti, Renato; Marcucci, Rossella | |
| P2697Percutaneous coronary intervention with 2nd generation drug eluting stent versus coronary artery bypass grafting in patients with unprotected left main disease: clinical outcome from a referral center | 2019 | Scudiero, F; Migliorini, A; Stefano, P L; Marcucci, R; Pennesi, M; Carrabba, N; Muraca, I; Vitale, R; Marchionni, N; Valenti, R | |
| Pathophysiological and Molecular Basis of the Side Effects of Ticagrelor: Lessons from a Case Report | 2023 | Cesarini, Daniel; Muraca, Iacopo; Berteotti, Martina; Gori, Anna Maria; Sorrentino, Andrea; Bertelli, Alessia; Marcucci, Rossella; Valenti, Renato | |
| Percutaneous coronary intervention with 2nd generation drug eluting stent versus coronary artery bypass grafting in patients with unprotected left main disease: clinical outcome from a referral center | 2019 | Scudiero, F; Migliorini, A; Stefano, PL; Marcucci, R; Pennesi, M; Carrabba, N; Muraca, I; Vitale, R; Marchionni, N; Valenti, R | |
| Percutaneous left ventricular advanced support for ‘protected’ complex high-risk transcatheter mitral valve repair: a case series | 2020 | Iacopo Muraca, Matteo Pennesi, Nazario Carrabba, Fernando Scudiero, Angela Migliorini, Niccolò Marchionni, Pierluigi Stefàno, Renato Valenti |